Cargando…
The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis
BACKGROUND: Dysbiotic intestinal and oral microbiota have been implicated in the pathogenesis of rheumatoid arthritis (RA), but the mechanisms how microbiota could impact disease activity have remained elusive. The aim of this study was to assess the association of the biological activity of serum l...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677706/ https://www.ncbi.nlm.nih.gov/pubmed/36411473 http://dx.doi.org/10.1186/s13075-022-02946-z |
_version_ | 1784833863353106432 |
---|---|
author | Parantainen, J. Barreto, G. Koivuniemi, R. Kautiainen, H. Nordström, D. Moilanen, E. Hämäläinen, M. Leirisalo-Repo, M. Nurmi, K. Eklund, K. K. |
author_facet | Parantainen, J. Barreto, G. Koivuniemi, R. Kautiainen, H. Nordström, D. Moilanen, E. Hämäläinen, M. Leirisalo-Repo, M. Nurmi, K. Eklund, K. K. |
author_sort | Parantainen, J. |
collection | PubMed |
description | BACKGROUND: Dysbiotic intestinal and oral microbiota have been implicated in the pathogenesis of rheumatoid arthritis (RA), but the mechanisms how microbiota could impact disease activity have remained elusive. The aim of this study was to assess the association of the biological activity of serum lipopolysaccharides (LPS) with disease activity and likelihood of achieving remission in RA patients. METHODS: We measured Toll-like receptor (TLR) 4-stimulating activity of sera of 58 RA patients with a reporter cell line engineered to produce secreted alkaline phosphatase in response to TLR4 stimulation. Levels of LPS-binding protein, CD14, and CD163 were determined by ELISA assays. RESULTS: The patient serum-induced TLR4 activation (biological activity of LPS) was significantly associated with inflammatory parameters and body mass index at baseline and at 12 months and with disease activity (DAS28-CRP, p<0.001) at 12 months. Importantly, baseline LPS bioactivity correlated with disease activity (p=0.031) and, in 28 early RA patients, the likelihood of achieving remission at 12 months (p=0.009). The level of LPS bioactivity was similar at baseline and 12-month visits, suggesting that LPS bioactivity is an independent patient-related factor. Neutralization of LPS in serum by polymyxin B abrogated the TLR4 signaling, suggesting that LPS was the major contributor to TLR4 activation. CONCLUSION: We describe a novel approach to study the biological activity of serum LPS and their impact in diseases. The results suggest that LPS contribute to the inflammatory burden and disease activity on patients with RA and that serum-induced TLR4 activation assays can serve as an independent prognostic factor. GRAPHICAL ABSTRACT: A graphical summary of the conclusions of the study. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-022-02946-z. |
format | Online Article Text |
id | pubmed-9677706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96777062022-11-22 The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis Parantainen, J. Barreto, G. Koivuniemi, R. Kautiainen, H. Nordström, D. Moilanen, E. Hämäläinen, M. Leirisalo-Repo, M. Nurmi, K. Eklund, K. K. Arthritis Res Ther Research BACKGROUND: Dysbiotic intestinal and oral microbiota have been implicated in the pathogenesis of rheumatoid arthritis (RA), but the mechanisms how microbiota could impact disease activity have remained elusive. The aim of this study was to assess the association of the biological activity of serum lipopolysaccharides (LPS) with disease activity and likelihood of achieving remission in RA patients. METHODS: We measured Toll-like receptor (TLR) 4-stimulating activity of sera of 58 RA patients with a reporter cell line engineered to produce secreted alkaline phosphatase in response to TLR4 stimulation. Levels of LPS-binding protein, CD14, and CD163 were determined by ELISA assays. RESULTS: The patient serum-induced TLR4 activation (biological activity of LPS) was significantly associated with inflammatory parameters and body mass index at baseline and at 12 months and with disease activity (DAS28-CRP, p<0.001) at 12 months. Importantly, baseline LPS bioactivity correlated with disease activity (p=0.031) and, in 28 early RA patients, the likelihood of achieving remission at 12 months (p=0.009). The level of LPS bioactivity was similar at baseline and 12-month visits, suggesting that LPS bioactivity is an independent patient-related factor. Neutralization of LPS in serum by polymyxin B abrogated the TLR4 signaling, suggesting that LPS was the major contributor to TLR4 activation. CONCLUSION: We describe a novel approach to study the biological activity of serum LPS and their impact in diseases. The results suggest that LPS contribute to the inflammatory burden and disease activity on patients with RA and that serum-induced TLR4 activation assays can serve as an independent prognostic factor. GRAPHICAL ABSTRACT: A graphical summary of the conclusions of the study. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-022-02946-z. BioMed Central 2022-11-21 2022 /pmc/articles/PMC9677706/ /pubmed/36411473 http://dx.doi.org/10.1186/s13075-022-02946-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Parantainen, J. Barreto, G. Koivuniemi, R. Kautiainen, H. Nordström, D. Moilanen, E. Hämäläinen, M. Leirisalo-Repo, M. Nurmi, K. Eklund, K. K. The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis |
title | The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis |
title_full | The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis |
title_fullStr | The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis |
title_full_unstemmed | The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis |
title_short | The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis |
title_sort | biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677706/ https://www.ncbi.nlm.nih.gov/pubmed/36411473 http://dx.doi.org/10.1186/s13075-022-02946-z |
work_keys_str_mv | AT parantainenj thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT barretog thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT koivuniemir thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT kautiainenh thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT nordstromd thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT moilanene thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT hamalainenm thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT leirisalorepom thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT nurmik thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT eklundkk thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT parantainenj biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT barretog biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT koivuniemir biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT kautiainenh biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT nordstromd biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT moilanene biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT hamalainenm biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT leirisalorepom biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT nurmik biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis AT eklundkk biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis |